openPR Logo
Press release

Global Bioresorbable Polymers Market to Reach USD 4.9 Billion by 2035, Expanding at a CAGR of 10.9%

04-30-2025 01:48 PM CET | Chemicals & Materials

Press release from: Future Market Insights Inc.

Bioresorbable Polymers Market

Bioresorbable Polymers Market

The global bioresorbable polymers market is projected to reach USD 1.7 billion in 2025 and is expected to witness robust growth over the coming decade, registering a compound annual growth rate (CAGR) of 10.9%. Driven by increasing demand in medical applications such as drug delivery systems, orthopedic devices, and tissue engineering, the market is anticipated to reach a value of USD 4.9 billion by 2035.

Bioresorbable polymers, also known as biodegradable polymers, are materials that gradually break down and are absorbed by the body after fulfilling their intended function. These materials eliminate the need for secondary surgeries to remove medical devices, making them particularly suitable for use in orthopedic implants, cardiovascular stents, tissue engineering scaffolds, and controlled drug delivery systems.

Request an Industry Overview Sample and Seize Growth Opportunities! https://www.futuremarketinsights.com/report-sample#5245502d47422d3135343033

Key Growth Drivers

Several underlying factors are propelling the growth of the bioresorbable polymers market:

1. Rising Incidence of Chronic Illnesses and Surgeries: With a global rise in conditions like cardiovascular disease, osteoporosis, and diabetes, the demand for advanced medical implants has increased. Bioresorbable materials are increasingly favored in these treatments due to their biocompatibility and elimination of removal procedures.

2. Technological Advancements: Continuous research and development in polymer chemistry and material science have led to the development of next-generation bioresorbable polymers with improved mechanical properties and controlled degradation rates. These enhancements have expanded the material's applicability to more complex medical scenarios.

3. Preference for Minimally Invasive Procedures: The healthcare industry's shift toward minimally invasive surgical techniques has catalyzed the use of bioresorbable materials, particularly in devices that are designed to temporarily support tissue healing and then dissolve naturally.

4. Sustainability in Biomedical Applications: With sustainability becoming a focal point across industries, bioresorbable polymers offer an eco-friendly alternative to traditional non-degradable materials used in implants and devices, aligning with global environmental and healthcare goals.

Exploring the Polymers and Plastics Industry: https://www.futuremarketinsights.com/industry-analysis/polymers-and-plastics

Regional Trends

North America remains a dominant force in the bioresorbable polymers market due to advanced healthcare infrastructure, strong investment in medical R&D, and high adoption rates of innovative therapies. Europe closely follows, supported by stringent regulatory frameworks that emphasize patient safety and efficacy.

Asia-Pacific is emerging as a high-growth region, fueled by rising healthcare expenditures, a growing aging population, and an expanding medical device manufacturing sector. Countries like China, India, and Japan are expected to be key contributors to the market's upward trajectory in the region.

Key players

• Corbion NV
• Evonik Industries AG
• Poly-Med Inc.
• Foster Corp.
• Abbott
• KLS Martin Group
• 3D Biotek LLC.
• Sunstar Suisse S.A.
• DSM
• Futerro

Discover Key Market Trends - Read the Complete Report! https://www.futuremarketinsights.com/reports/bioresorbable-polymers-market

Segmentation

By Product:
With respect to product, the market is classified into polysaccharides, proteins bioresorbable, polylactic acid, polyglycolic acid, polycaprolactone, and others.

By Application:
In terms of application, the market is divided into drug delivery, orthopedics, and others.

By Region:
In terms of region, the market is segmented into North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA.

Have a Look at Related Research Reports of Chemicals & Materials

Perfluoropolyether (PFPE) Market Outlook: https://www.futuremarketinsights.com/reports/perfluoropolyether-market

Basic Methacrylate Copolymer Market Growth: https://www.futuremarketinsights.com/reports/basic-methacrylate-copolymer-market

Polyvinylidene Fluoride (PVDF) Market Trends: https://www.futuremarketinsights.com/reports/global-polyvinylidene-fluoride-market

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Bioresorbable Polymers Market to Reach USD 4.9 Billion by 2035, Expanding at a CAGR of 10.9% here

News-ID: 3994880 • Views:

More Releases from Future Market Insights Inc.

Global Inherited Orphan Blood Disorders Therapeutics Market to Grow at 9.0% CAGR from 2025 to 2035, Reaching USD 4.2 Billion by 2035.
Global Inherited Orphan Blood Disorders Therapeutics Market to Grow at 9.0% CAGR …
The global market for Inherited Orphan Blood Disorders Therapeutics is poised for substantial growth over the next decade, with projections estimating the market to expand from USD 1.8 billion in 2025 to USD 4.2 billion by 2035. This represents a compound annual growth rate (CAGR) of 9.0%, reflecting the increasing need for targeted therapeutic solutions for rare genetic blood disorders. Inherited orphan blood disorders, such as sickle cell anemia, thalassemia, and
The Cardiovascular Surgical Devices Market: A Key Focus on Growth and Innovation in Cardiac Healthcare
The Cardiovascular Surgical Devices Market: A Key Focus on Growth and Innovation …
The cardiovascular surgical devices market is undergoing a dynamic transformation, offering significant opportunities for healthcare providers, medical device manufacturers, and patients alike. With an estimated market value of USD 57.9 billion in 2025, the sector is projected to experience robust growth, reaching USD 122.7 billion by 2035. This impressive expansion, at a compound annual growth rate (CAGR) of 7.8%, is propelled by a convergence of factors including the rising incidence
Surgical Heart Valves Market Poised for Unprecedented Growth, Projected to Reach USD 36.6 Billion by 2035
Surgical Heart Valves Market Poised for Unprecedented Growth, Projected to Reach …
The surgical heart valves market is entering a new era of expansion, projected to grow from USD 8,897.2 million in 2025 to a staggering USD 36,625.0 million by 2035. With a remarkable compound annual growth rate (CAGR) of 15.2% during the forecast period, the sector is set to be one of the fastest-growing segments within the global cardiovascular medical devices industry. As the world grapples with rising cardiovascular disease rates
Paediatric Oncology Therapeutics Market Set for Robust Growth, Projected to Reach USD 6.3 Billion by 2035
Paediatric Oncology Therapeutics Market Set for Robust Growth, Projected to Reac …
The global paediatric oncology therapeutics market is poised for significant growth, with a projected compound annual growth rate (CAGR) of 8.0%, reaching a market value of USD 6.3 billion by 2035, up from USD 2.9 billion in 2025. This surge is driven by the increasing prevalence of childhood cancers and the escalating demand for advanced, age-specific treatment options. As the global incidence of paediatric cancers rises, the need for effective, safe,

All 5 Releases


More Releases for Bioresorbable

Bioresorbable Vascular Scaffold Market A Scaffolding Revolution: The Soaring Bio …
Bioresorbable Vascular Scaffold Market worth $300.21 Mn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Bioresorbable Vascular Scaffold Market- (By Product Type (Enviroximes-eluting Device, Novalis's-eluting Device, Sirolimus-eluting Device. Others), By Disease Type (Coronary Artery Disease, Peripheral Artery Disease), By Material Type (Poly-L-Lactic Acid (PLLA), Tyrosine-derived Polycarbonate, Others), By End-user (Hospital, Ambulatory Surgical Center, Cardiac
Unlocking Prosperity: Bioresorbable Polymers Market Insights
𝐆𝐫𝐨𝐰𝐭𝐡 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬, a renowned Market research firm, introduces its latest research report on the 𝐁𝐢𝐨𝐫𝐞𝐬𝐨𝐫𝐛𝐚𝐛𝐥𝐞 𝐏𝐨𝐥𝐲𝐦𝐞𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭, providing a detailed guide for businesses seeking growth progression. This report is meticulously crafted to aid in investment decisions, offering crucial insights and encouraging strategic investment discretion for new entrants aiming for seamless Market penetration. 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐁𝐢𝐨𝐫𝐞𝐬𝐨𝐫𝐛𝐚𝐛𝐥𝐞 𝐏𝐨𝐥𝐲𝐦𝐞𝐫𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 https://growthmarketreports.com/request-sample/5738 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐨𝐟 𝐁𝐢𝐨𝐫𝐞𝐬𝐨𝐫𝐛𝐚𝐛𝐥𝐞 𝐏𝐨𝐥𝐲𝐦𝐞𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭: The global bioresorbable polymers market
Growing Demand for Bioresorbable Medical Implants to Drive Bioresorbable Polymer …
According to our latest market study, titled "Bioresorbable Polymers Market to 2028- Covid-19 Impact and Global Analysis by Type [Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polydioxanone, Polycaprolactone (PCL), and Others] and Application (Orthopedic Devices, Drug Delivery, and Others),'' The bioresorbable polymers market was valued at US$ 3,260.07 million in 2021 and is projected to reach US$ 6,463.07 million by 2028. It is expected to grow at a CAGR of 10.3%
Bioresorbable Polymers Market Future Business Status and Prospects Bioresorbable …
(Latest Industry Report 2022) Bioresorbable Polymers Market report provides a basic overview of the industry including definitions and classifications. The market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. The study provides a complex examination of the application, including a detailed cost assessment analysis of the products available in the global market with respect to the profit margins of established
Bioresorbable Implants Market Future Adoption Overview 2028
Global Bioresorbable Implants Market: Overview The global bioresorable implants market is gaining traction, owing to the convenience it provides to the healthcare sector in improving the damaged and injured biological structures. Previously, the conventional implants were highly used by orthopedic surgeons for fixing several internal structures. These traditional implants have required a lot of advancement and development over the decades. However, the advanced form of implants which is also known as
Bioresorbable Implants Market Snapshot by 2017 – 2025
Global Bioresorbable Implants Market: Key Players Currently, the global bioresorbable implants market is highly competitive owing to the involvement of many established players. Some of the key players in the global bioresorbable implants market are Bioretec, DePuy Synthes, Stryker, Smith & Nephew, Biomet, Medtronic and Nu Vasive. Conventional implants were used by orthopedic surgeons previously to fix internal fixation for years. These implants have required a lot of development over the decades.